Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1950 1
1957 2
1958 2
1959 1
1960 1
1961 1
1962 4
1963 3
1964 5
1965 5
1966 7
1967 10
1968 8
1969 8
1970 8
1971 15
1972 14
1973 21
1974 23
1975 19
1976 24
1977 26
1978 31
1979 31
1980 38
1981 40
1982 28
1983 39
1984 34
1985 44
1986 56
1987 53
1988 65
1989 66
1990 62
1991 58
1992 78
1993 72
1994 85
1995 82
1996 87
1997 78
1998 89
1999 102
2000 111
2001 109
2002 122
2003 178
2004 199
2005 208
2006 225
2007 259
2008 286
2009 281
2010 353
2011 396
2012 392
2013 438
2014 471
2015 432
2016 491
2017 513
2018 540
2019 500
2020 543
2021 675
2022 400
Text availability
Article attribute
Article type
Publication date

Search Results

8,734 results
Results by year
Filters applied: . Clear all
Page 1
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study.
Lenz HJ, Van Cutsem E, Luisa Limon M, Wong KYM, Hendlisz A, Aglietta M, García-Alfonso P, Neyns B, Luppi G, Cardin DB, Dragovich T, Shah U, Abdullaev S, Gricar J, Ledeine JM, Overman MJ, Lonardi S. Lenz HJ, et al. Among authors: wong kym. J Clin Oncol. 2022 Jan 10;40(2):161-170. doi: 10.1200/JCO.21.01015. Epub 2021 Oct 12. J Clin Oncol. 2022. PMID: 34637336 Clinical Trial.
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity.
Hu H, Khodadadi-Jamayran A, Dolgalev I, Cho H, Badri S, Chiriboga LA, Zeck B, Lopez De Rodas Gregorio M, Dowling CM, Labbe K, Deng J, Chen T, Zhang H, Zappile P, Chen Z, Ueberheide B, Karatza A, Han H, Ranieri M, Tang S, Jour G, Osman I, Sucker A, Schadendorf D, Tsirigos A, Schalper KA, Velcheti V, Huang HY, Jin Y, Ji H, Poirier JT, Li F, Wong KK. Hu H, et al. Among authors: wong kk. Cancer Immunol Res. 2021 Nov;9(11):1298-1315. doi: 10.1158/2326-6066.CIR-21-0543. Epub 2021 Aug 30. Cancer Immunol Res. 2021. PMID: 34462284
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.
Chang CA, Jen J, Jiang S, Sayad A, Mer AS, Brown KR, Nixon AML, Dhabaria A, Tang KH, Venet D, Sotiriou C, Deng J, Wong KK, Adams S, Meyn P, Heguy A, Skok JA, Tsirigos A, Ueberheide B, Moffat J, Singh A, Haibe-Kains B, Khodadadi-Jamayran A, Neel BG. Chang CA, et al. Among authors: wong kk. Cancer Discov. 2022 Apr 1;12(4):1022-1045. doi: 10.1158/2159-8290.CD-20-1265. Cancer Discov. 2022. PMID: 34911733
Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non-small cell lung cancer.
Huang Q, Li F, Hu H, Fang Z, Gao Z, Xia G, Ng WL, Khodadadi-Jamayran A, Chen T, Deng J, Zhang H, Almonte C, Labbe K, Han H, Geng K, Tang S, Freeman GJ, Li Y, Chen H, Wong KK. Huang Q, et al. Among authors: wong kk. Sci Adv. 2022 Feb 4;8(5):eabi9533. doi: 10.1126/sciadv.abi9533. Epub 2022 Feb 4. Sci Adv. 2022. PMID: 35119931 Free PMC article.
Implantable system for chronotherapy.
Lee SH, Wan Q, Wentworth A, Ballinger I, Ishida K, Collins JE, Tamang S, Huang HW, Li C, Hess K, Lopes A, Kirtane AR, Lee JS, Lee S, Chen W, Wong K, Selsing G, Kim H, Buckley ST, Hayward A, Langer R, Traverso G. Lee SH, et al. Among authors: wong k. Sci Adv. 2021 Nov 26;7(48):eabj4624. doi: 10.1126/sciadv.abj4624. Epub 2021 Nov 26. Sci Adv. 2021. PMID: 34826238 Free PMC article.
Spotlight: Rising stars in cytology.
Wong KS. Wong KS. Cancer Cytopathol. 2021 Nov;129(11):839-840. doi: 10.1002/cncy.22518. Epub 2021 Oct 7. Cancer Cytopathol. 2021. PMID: 34618412 No abstract available.
8,734 results